radiolabeled LSD1 antagonist (Takeda/InVicro)

N/A

Report date: 2025/03/20 09:16:27

Base Information

Drug Nameradiolabeled LSD1 antagonist (Takeda/InVicro)
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsCentral nervous system development disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdInvicro Llc
Inactive CompaniesN/A
Active IndicationsCentral nervous system development disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A